How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

EV

NASDAQ:EVGN
Get a brief AI stock analysisSaves ~ 15 minutes of your time

EV

Evogene LtdNASDAQ EVGN Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is EVGN undervalued compared to its fair value?

The fair value of EVGN stock is hidden USD. Relative to the market price of 0.621 USD Evogene Ltd is hidden.

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intell...[More about valuation]

Evogene Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.03 $B

Price:

0.621 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.076

FINANCIALS

Evogene financial for reporting period

Income Statement

0.0042 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0036 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0039 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0042 B 100%
0.0039 B 93%
-0.0036 B -85%
-0.0039 B -92%

Balance Sheet

0.047 B
0.0083 B

0.011 B

Financial Position Analysis

Assets

0.047 B
Current Assets
0.031 B
Total non-current assets
0.016 B

Total current liabilities
0.0061 B
Total non-current liabilities
0.032 B

Cash Flow Statement

-0.0046 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0041 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Evogene fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-162 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-159 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-41 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is EVGN attractive for investment based on fundamental analysis?

EVGN stock rating is hidden. Evogene is a hidden by Eyestock methodology.

Get EVGN Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-234

Gross Margin:

82

CFO / Debt ratio:

hidden

Current ratio:

5.461

Debt / Equity ratio:

0.869

ROE:

-162

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

EVGN analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for EVGN to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Evogene Ltd competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Evogene Ltd dividends

EVGN dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About EVGN stock

About the company Evogene Ltd

Market cap $B

0.03

Dividend yield

Shares outstanding

41.2444 B

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

EVGN profile

  • Ticker

    EVGN

  • Country

    Israel

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    11 June 2007

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    141

  • City

    Rehovot

  • Address

    Park Rehovot P.O.B 2100, 13 Gad Feinstein Street

  • Cusip

    M4119S104